ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Solid Dosage Form Drug Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-13F13972
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Solid Dosage Form Drug Market Research Report 2023
BUY CHAPTERS

Global Solid Dosage Form Drug Market Research Report 2025

Code: QYRE-Auto-13F13972
Report
May 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
TEVA
Boehringer Ingelheim
Biogen
Astellas

Solid Dosage Form Drug Market Size

The global market for Solid Dosage Form Drug was valued at US$ 617970 million in the year 2024 and is projected to reach a revised size of US$ 948290 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Solid Dosage Form Drug Market

Solid Dosage Form Drug Market

Solid dosage form means any of the many pharmacy dosage forms like tablets, capsules, caplets, pills, powders, troches, lozenges, cachets, pellets or confections which are solid and which are not in liquid or gaseous form.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Solid Dosage Form Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Solid Dosage Form Drug.
The Solid Dosage Form Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Solid Dosage Form Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Solid Dosage Form Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Solid Dosage Form Drug Market Report

Report Metric Details
Report Name Solid Dosage Form Drug Market
Accounted market size in year US$ 617970 million
Forecasted market size in 2031 US$ 948290 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
  • Tablet
  • Capsules
  • Other
Segment by Application
  • Hospital
  • Retail Pharmacy
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Teva, Boehringer Ingelheim, Biogen, Astellas
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Solid Dosage Form Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Solid Dosage Form Drug Market growing?

Ans: The Solid Dosage Form Drug Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Solid Dosage Form Drug Market size in 2031?

Ans: The Solid Dosage Form Drug Market size in 2031 will be US$ 948290 million.

Who are the main players in the Solid Dosage Form Drug Market report?

Ans: The main players in the Solid Dosage Form Drug Market are Johnson & Johnson, Novartis, Roche, AbbVie, Merck & Co., Bristol Myers Squibb, GlaxoSmithKline, Pfizer, Sanofi, Takeda, AstraZeneca, Bayer, Eli Lilly & Co., Gilead Sciences, Amgen, Teva, Boehringer Ingelheim, Biogen, Astellas

What are the Application segmentation covered in the Solid Dosage Form Drug Market report?

Ans: The Applications covered in the Solid Dosage Form Drug Market report are Hospital, Retail Pharmacy, Other

What are the Type segmentation covered in the Solid Dosage Form Drug Market report?

Ans: The Types covered in the Solid Dosage Form Drug Market report are Tablet, Capsules, Other

Recommended Reports

Drug Delivery Systems

Oral Solid Dosage

Pharma Industry Supply

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Solid Dosage Form Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Tablet
1.2.3 Capsules
1.2.4 Other
1.3 Market by Application
1.3.1 Global Solid Dosage Form Drug Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Solid Dosage Form Drug Market Perspective (2020-2031)
2.2 Global Solid Dosage Form Drug Growth Trends by Region
2.2.1 Global Solid Dosage Form Drug Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Solid Dosage Form Drug Historic Market Size by Region (2020-2025)
2.2.3 Solid Dosage Form Drug Forecasted Market Size by Region (2026-2031)
2.3 Solid Dosage Form Drug Market Dynamics
2.3.1 Solid Dosage Form Drug Industry Trends
2.3.2 Solid Dosage Form Drug Market Drivers
2.3.3 Solid Dosage Form Drug Market Challenges
2.3.4 Solid Dosage Form Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Solid Dosage Form Drug Players by Revenue
3.1.1 Global Top Solid Dosage Form Drug Players by Revenue (2020-2025)
3.1.2 Global Solid Dosage Form Drug Revenue Market Share by Players (2020-2025)
3.2 Global Solid Dosage Form Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Solid Dosage Form Drug Revenue
3.4 Global Solid Dosage Form Drug Market Concentration Ratio
3.4.1 Global Solid Dosage Form Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Solid Dosage Form Drug Revenue in 2024
3.5 Global Key Players of Solid Dosage Form Drug Head office and Area Served
3.6 Global Key Players of Solid Dosage Form Drug, Product and Application
3.7 Global Key Players of Solid Dosage Form Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Solid Dosage Form Drug Breakdown Data by Type
4.1 Global Solid Dosage Form Drug Historic Market Size by Type (2020-2025)
4.2 Global Solid Dosage Form Drug Forecasted Market Size by Type (2026-2031)
5 Solid Dosage Form Drug Breakdown Data by Application
5.1 Global Solid Dosage Form Drug Historic Market Size by Application (2020-2025)
5.2 Global Solid Dosage Form Drug Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Solid Dosage Form Drug Market Size (2020-2031)
6.2 North America Solid Dosage Form Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Solid Dosage Form Drug Market Size by Country (2020-2025)
6.4 North America Solid Dosage Form Drug Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Solid Dosage Form Drug Market Size (2020-2031)
7.2 Europe Solid Dosage Form Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Solid Dosage Form Drug Market Size by Country (2020-2025)
7.4 Europe Solid Dosage Form Drug Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Solid Dosage Form Drug Market Size (2020-2031)
8.2 Asia-Pacific Solid Dosage Form Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Solid Dosage Form Drug Market Size by Region (2020-2025)
8.4 Asia-Pacific Solid Dosage Form Drug Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Solid Dosage Form Drug Market Size (2020-2031)
9.2 Latin America Solid Dosage Form Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Solid Dosage Form Drug Market Size by Country (2020-2025)
9.4 Latin America Solid Dosage Form Drug Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Solid Dosage Form Drug Market Size (2020-2031)
10.2 Middle East & Africa Solid Dosage Form Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Solid Dosage Form Drug Market Size by Country (2020-2025)
10.4 Middle East & Africa Solid Dosage Form Drug Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Details
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Solid Dosage Form Drug Introduction
11.1.4 Johnson & Johnson Revenue in Solid Dosage Form Drug Business (2020-2025)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Solid Dosage Form Drug Introduction
11.2.4 Novartis Revenue in Solid Dosage Form Drug Business (2020-2025)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche Solid Dosage Form Drug Introduction
11.3.4 Roche Revenue in Solid Dosage Form Drug Business (2020-2025)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Details
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Solid Dosage Form Drug Introduction
11.4.4 AbbVie Revenue in Solid Dosage Form Drug Business (2020-2025)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Solid Dosage Form Drug Introduction
11.5.4 Merck & Co. Revenue in Solid Dosage Form Drug Business (2020-2025)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Details
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Solid Dosage Form Drug Introduction
11.6.4 Bristol Myers Squibb Revenue in Solid Dosage Form Drug Business (2020-2025)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Details
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Solid Dosage Form Drug Introduction
11.7.4 GlaxoSmithKline Revenue in Solid Dosage Form Drug Business (2020-2025)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Solid Dosage Form Drug Introduction
11.8.4 Pfizer Revenue in Solid Dosage Form Drug Business (2020-2025)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Solid Dosage Form Drug Introduction
11.9.4 Sanofi Revenue in Solid Dosage Form Drug Business (2020-2025)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Details
11.10.2 Takeda Business Overview
11.10.3 Takeda Solid Dosage Form Drug Introduction
11.10.4 Takeda Revenue in Solid Dosage Form Drug Business (2020-2025)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Solid Dosage Form Drug Introduction
11.11.4 AstraZeneca Revenue in Solid Dosage Form Drug Business (2020-2025)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Details
11.12.2 Bayer Business Overview
11.12.3 Bayer Solid Dosage Form Drug Introduction
11.12.4 Bayer Revenue in Solid Dosage Form Drug Business (2020-2025)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Details
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Solid Dosage Form Drug Introduction
11.13.4 Eli Lilly & Co. Revenue in Solid Dosage Form Drug Business (2020-2025)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Details
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Solid Dosage Form Drug Introduction
11.14.4 Gilead Sciences Revenue in Solid Dosage Form Drug Business (2020-2025)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Details
11.15.2 Amgen Business Overview
11.15.3 Amgen Solid Dosage Form Drug Introduction
11.15.4 Amgen Revenue in Solid Dosage Form Drug Business (2020-2025)
11.15.5 Amgen Recent Development
11.16 Teva
11.16.1 Teva Company Details
11.16.2 Teva Business Overview
11.16.3 Teva Solid Dosage Form Drug Introduction
11.16.4 Teva Revenue in Solid Dosage Form Drug Business (2020-2025)
11.16.5 Teva Recent Development
11.17 Boehringer Ingelheim
11.17.1 Boehringer Ingelheim Company Details
11.17.2 Boehringer Ingelheim Business Overview
11.17.3 Boehringer Ingelheim Solid Dosage Form Drug Introduction
11.17.4 Boehringer Ingelheim Revenue in Solid Dosage Form Drug Business (2020-2025)
11.17.5 Boehringer Ingelheim Recent Development
11.18 Biogen
11.18.1 Biogen Company Details
11.18.2 Biogen Business Overview
11.18.3 Biogen Solid Dosage Form Drug Introduction
11.18.4 Biogen Revenue in Solid Dosage Form Drug Business (2020-2025)
11.18.5 Biogen Recent Development
11.19 Astellas
11.19.1 Astellas Company Details
11.19.2 Astellas Business Overview
11.19.3 Astellas Solid Dosage Form Drug Introduction
11.19.4 Astellas Revenue in Solid Dosage Form Drug Business (2020-2025)
11.19.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Novartis
Roche
AbbVie
Merck
Bristol–Myers Squibb
GlaxoSmithKline PLC
Pfizer Inc
Sanofi
Takeda
Astrazeneca plc
Bayer
Eli Lilly & Co
Gilead Sciences
Amgen Inc
TEVA
Boehringer Ingelheim
Biogen
Astellas
List of Tables
 Table 1. Global Solid Dosage Form Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Tablet
 Table 3. Key Players of Capsules
 Table 4. Key Players of Other
 Table 5. Global Solid Dosage Form Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Solid Dosage Form Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Solid Dosage Form Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Solid Dosage Form Drug Market Share by Region (2020-2025)
 Table 9. Global Solid Dosage Form Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Solid Dosage Form Drug Market Share by Region (2026-2031)
 Table 11. Solid Dosage Form Drug Market Trends
 Table 12. Solid Dosage Form Drug Market Drivers
 Table 13. Solid Dosage Form Drug Market Challenges
 Table 14. Solid Dosage Form Drug Market Restraints
 Table 15. Global Solid Dosage Form Drug Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Solid Dosage Form Drug Market Share by Players (2020-2025)
 Table 17. Global Top Solid Dosage Form Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Dosage Form Drug as of 2024)
 Table 18. Ranking of Global Top Solid Dosage Form Drug Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Solid Dosage Form Drug Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Solid Dosage Form Drug, Headquarters and Area Served
 Table 21. Global Key Players of Solid Dosage Form Drug, Product and Application
 Table 22. Global Key Players of Solid Dosage Form Drug, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Solid Dosage Form Drug Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Solid Dosage Form Drug Revenue Market Share by Type (2020-2025)
 Table 26. Global Solid Dosage Form Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Solid Dosage Form Drug Revenue Market Share by Type (2026-2031)
 Table 28. Global Solid Dosage Form Drug Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Solid Dosage Form Drug Revenue Market Share by Application (2020-2025)
 Table 30. Global Solid Dosage Form Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Solid Dosage Form Drug Revenue Market Share by Application (2026-2031)
 Table 32. North America Solid Dosage Form Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Solid Dosage Form Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Solid Dosage Form Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Solid Dosage Form Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Solid Dosage Form Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Solid Dosage Form Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Solid Dosage Form Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Solid Dosage Form Drug Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Solid Dosage Form Drug Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Solid Dosage Form Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Solid Dosage Form Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Solid Dosage Form Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Solid Dosage Form Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Solid Dosage Form Drug Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Solid Dosage Form Drug Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Johnson & Johnson Company Details
 Table 48. Johnson & Johnson Business Overview
 Table 49. Johnson & Johnson Solid Dosage Form Drug Product
 Table 50. Johnson & Johnson Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 51. Johnson & Johnson Recent Development
 Table 52. Novartis Company Details
 Table 53. Novartis Business Overview
 Table 54. Novartis Solid Dosage Form Drug Product
 Table 55. Novartis Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 56. Novartis Recent Development
 Table 57. Roche Company Details
 Table 58. Roche Business Overview
 Table 59. Roche Solid Dosage Form Drug Product
 Table 60. Roche Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 61. Roche Recent Development
 Table 62. AbbVie Company Details
 Table 63. AbbVie Business Overview
 Table 64. AbbVie Solid Dosage Form Drug Product
 Table 65. AbbVie Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 66. AbbVie Recent Development
 Table 67. Merck & Co. Company Details
 Table 68. Merck & Co. Business Overview
 Table 69. Merck & Co. Solid Dosage Form Drug Product
 Table 70. Merck & Co. Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 71. Merck & Co. Recent Development
 Table 72. Bristol Myers Squibb Company Details
 Table 73. Bristol Myers Squibb Business Overview
 Table 74. Bristol Myers Squibb Solid Dosage Form Drug Product
 Table 75. Bristol Myers Squibb Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 76. Bristol Myers Squibb Recent Development
 Table 77. GlaxoSmithKline Company Details
 Table 78. GlaxoSmithKline Business Overview
 Table 79. GlaxoSmithKline Solid Dosage Form Drug Product
 Table 80. GlaxoSmithKline Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 81. GlaxoSmithKline Recent Development
 Table 82. Pfizer Company Details
 Table 83. Pfizer Business Overview
 Table 84. Pfizer Solid Dosage Form Drug Product
 Table 85. Pfizer Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 86. Pfizer Recent Development
 Table 87. Sanofi Company Details
 Table 88. Sanofi Business Overview
 Table 89. Sanofi Solid Dosage Form Drug Product
 Table 90. Sanofi Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 91. Sanofi Recent Development
 Table 92. Takeda Company Details
 Table 93. Takeda Business Overview
 Table 94. Takeda Solid Dosage Form Drug Product
 Table 95. Takeda Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 96. Takeda Recent Development
 Table 97. AstraZeneca Company Details
 Table 98. AstraZeneca Business Overview
 Table 99. AstraZeneca Solid Dosage Form Drug Product
 Table 100. AstraZeneca Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 101. AstraZeneca Recent Development
 Table 102. Bayer Company Details
 Table 103. Bayer Business Overview
 Table 104. Bayer Solid Dosage Form Drug Product
 Table 105. Bayer Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 106. Bayer Recent Development
 Table 107. Eli Lilly & Co. Company Details
 Table 108. Eli Lilly & Co. Business Overview
 Table 109. Eli Lilly & Co. Solid Dosage Form Drug Product
 Table 110. Eli Lilly & Co. Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 111. Eli Lilly & Co. Recent Development
 Table 112. Gilead Sciences Company Details
 Table 113. Gilead Sciences Business Overview
 Table 114. Gilead Sciences Solid Dosage Form Drug Product
 Table 115. Gilead Sciences Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 116. Gilead Sciences Recent Development
 Table 117. Amgen Company Details
 Table 118. Amgen Business Overview
 Table 119. Amgen Solid Dosage Form Drug Product
 Table 120. Amgen Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 121. Amgen Recent Development
 Table 122. Teva Company Details
 Table 123. Teva Business Overview
 Table 124. Teva Solid Dosage Form Drug Product
 Table 125. Teva Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 126. Teva Recent Development
 Table 127. Boehringer Ingelheim Company Details
 Table 128. Boehringer Ingelheim Business Overview
 Table 129. Boehringer Ingelheim Solid Dosage Form Drug Product
 Table 130. Boehringer Ingelheim Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 131. Boehringer Ingelheim Recent Development
 Table 132. Biogen Company Details
 Table 133. Biogen Business Overview
 Table 134. Biogen Solid Dosage Form Drug Product
 Table 135. Biogen Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 136. Biogen Recent Development
 Table 137. Astellas Company Details
 Table 138. Astellas Business Overview
 Table 139. Astellas Solid Dosage Form Drug Product
 Table 140. Astellas Revenue in Solid Dosage Form Drug Business (2020-2025) & (US$ Million)
 Table 141. Astellas Recent Development
 Table 142. Research Programs/Design for This Report
 Table 143. Key Data Information from Secondary Sources
 Table 144. Key Data Information from Primary Sources
 Table 145. Authors List of This Report


List of Figures
 Figure 1. Solid Dosage Form Drug Picture
 Figure 2. Global Solid Dosage Form Drug Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Solid Dosage Form Drug Market Share by Type: 2024 VS 2031
 Figure 4. Tablet Features
 Figure 5. Capsules Features
 Figure 6. Other Features
 Figure 7. Global Solid Dosage Form Drug Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Solid Dosage Form Drug Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Retail Pharmacy Case Studies
 Figure 11. Other Case Studies
 Figure 12. Solid Dosage Form Drug Report Years Considered
 Figure 13. Global Solid Dosage Form Drug Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Solid Dosage Form Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Solid Dosage Form Drug Market Share by Region: 2024 VS 2031
 Figure 16. Global Solid Dosage Form Drug Market Share by Players in 2024
 Figure 17. Global Top Solid Dosage Form Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Solid Dosage Form Drug as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Solid Dosage Form Drug Revenue in 2024
 Figure 19. North America Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Solid Dosage Form Drug Market Share by Country (2020-2031)
 Figure 21. United States Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Solid Dosage Form Drug Market Share by Country (2020-2031)
 Figure 25. Germany Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Solid Dosage Form Drug Market Share by Region (2020-2031)
 Figure 33. China Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Solid Dosage Form Drug Market Share by Country (2020-2031)
 Figure 41. Mexico Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Solid Dosage Form Drug Market Share by Country (2020-2031)
 Figure 45. Turkey Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Solid Dosage Form Drug Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Johnson & Johnson Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 49. Novartis Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 50. Roche Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 51. AbbVie Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 52. Merck & Co. Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 53. Bristol Myers Squibb Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 54. GlaxoSmithKline Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 55. Pfizer Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 56. Sanofi Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 57. Takeda Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 58. AstraZeneca Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 59. Bayer Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 60. Eli Lilly & Co. Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 61. Gilead Sciences Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 62. Amgen Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 63. Teva Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 64. Boehringer Ingelheim Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 65. Biogen Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 66. Astellas Revenue Growth Rate in Solid Dosage Form Drug Business (2020-2025)
 Figure 67. Bottom-up and Top-down Approaches for This Report
 Figure 68. Data Triangulation
 Figure 69. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Solid Preparation Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Solid Dosage Pharmaceutical Excipients Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Solid Dosage Pharmaceutical Formulation Market Research Report 2024
Global Oral Solid Dosage Medicine Market Research Report 2025
Global Oral Solid Dose Market Research Report 2024
Global Pharmaceutical Pellet Core Market Research Report 2024
Global Pharmaceutical Spheres Market Research Report 2024
Global Pharmaceutical Neutral Pellet Market Research Report 2024
Global Semi Solid Dose Market Research Report 2024
Global Dosage Form Development Service Market Research Report 2025
Gel Capsule Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Suspension Market Research Report 2024
Oral Dose Packaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pharmaceutical Pellet Spheronizers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Pharmaceutical Excipients Market Research Report 2025
Global Solid Dosage Form Packaging Equipment Market Research Report 2024
Global Semi Solid Formulations Drug Delivery Market Research Report 2025
Global External Semi Solid Preparation Market Research Report 2024
Oral Solid Dosage Formulation Development Service Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Solid Dosage Manufacturing Market Research Report 2025

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions